Gilead Sciences, Inc. (NASDAQ:GILD) and Pfizer Inc. (NYSE:PFE) are some of the major drug companies that have recently raised the list prices of their medicines.

On Friday, Shares of Pfizer Inc. (NYSE:PFE) gained 0.98% to $36.12. The share price is trading in a range of $35.70 - $36.19.

Pfizer Inc. currently has a total float of 6.06 billion shares and moves 25.19 million a day, on average. The stock opened at $36.07 on July 11 and traded between a low of $36.03 and a high of $36.35.

Pfizer Inc., Bayer, Merck, Patterson Companies, Showa Yakuhin Kako Co., Ltd., Hospira, Valeant Pharmaceuticals North America LLC.

Boy are things getting excited at Pfizer (NYSE:PFE). The company's shares are breaking out to the upside, and both investors seeking income and capital appreciation have been pleased in recent years.

In the liquidity ratio analysis; Pfizer Inc.'s (PFE) debt to equity ratio was 0.62 while current ratio was 1.40. The company has the institutional ownership of 76.50% while the Beta factor was 0.82.

Pfizer, Inc. (NYSE:PFE) negotiated 17.79 million shares against it an average volume of 28.98 million shares. The stock concluded the recent trade at $36.12 with upbeat trend move of +0.98%.

Pfizer Inc. (NYSE:PFE) is expected to announce second quarter financial results before market open (confirmed) on August 02, 2016.

Pfizer Inc. (NYSE:PFE) seems to have resumed its acquisition spree focused on small but high-growth purchases. The shift towards smaller purchases is not surprising after the pharmaceutical giant broke off from its $160 mega merger deal with Allergan ...

Pfizer Inc. (NYSE:PFE) has embarked on a process of upgrading its biologics plant in Dublin, Ireland. The company said it was in the process of submitting the plans for expansion of the facility to local authorities.